Kimberly Hollabaugh

Hollabaugh 2017636439409530462445


Phone: (405) 271-2229 x46728
Office: The University of Oklahoma Health Sciences Center
801 NE 13th St, Room 112g
Post Office Box 26901
Oklahoma City, OK 73126-0901
Research Profile:


  • M.S. in Biostatistics,  University of Oklahoma Health Sciences Center, 2010
  • B.S. in Mathematics, University of Oklahoma, 2010

Appointments and Positions:

  • Instructor, Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, 2017-Present

Complete List of Publications:

Most Recent 5 Publications:

  • Naggie S, Marks KM, Hughes M, Fierer DS, Macbrayne C, Kim A, Hollabaugh K, Roa J, Symonds B, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Chung R. Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C. Clin Infect  Dis. 2017 Feb 27;PubMed PMID: 28329053.
  • Bedimo R, Kang M, Tebas P, Overton ET, Hollabaugh K, McComsey G, Bhattacharya D, Evans C, Brown TT, Taiwo B. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Res Hum Retroviruses. 2016 Apr;32(4):325-8. PubMed PMID: 26499270; PubMed Central PMCID: PMC4817562.
  • Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS. 2015 Jun 19;29(10):1173-82.  PubMed PMID: 26035319; NIHMSID: NIHMS712903; PubMed Central PMCID: PMC4535336.
  • de Armendi AJ, Butt AL, Shukry M, Cure JA, Hollabaugh K.  A randomized, single-blinded, prospective study that compares complications between cuffed and uncuffed nasal endotracheal tubes of different sizes and brands in pediatric patients.  J Clin Anesth. 2015 May;27(3):221-5. PubMed PMID: 25516395.
  • Kang M, Hollabaugh K, Pham V, Koletar SL, Wu K, Smurzynski M, Aberg JA. Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. J Acquir Immune Defic Syndr. 2014 Jun 01; 66(2):172-80. PMID: 24694927; PMCID: PMC4169110.

Research Grants:

Research Interests:

  • Cardiovascular Health
  • Tobacco-related health disparities
  • SAS programming and standardization